Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Guidelines for Authors

Conflicts of Interest
Categories of Manuscripts
Reporting Guidelines
Plagiarism Policy
Color Illustrations
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Page Charges


'Neuroepidemiology' is a peer-reviewed international journal that publishes manuscripts on all aspects of epidemiology of neurological disorders, including clinical trials and systematic reviews. Its primary focus is on chronic and acute neurological disorders of major importance to clinical medicine, public health, and health care delivery.

The journal encourages the use of epidemiology in a multidisciplinary approach to the understanding of neurological disease distribution and determinants of frequency in human populations. The journal also welcomes manuscripts dealing with methodological issues in neuroepidemiological studies.

Fast-track evaluation and publication will be secured by online submission, evaluation, and prompt decision, as well as by fast on-line publication of accepted manuscripts, followed by their hard-copy publication.


Only original papers written in English are considered and should be submitted online:

Online Manuscript Submission

Should you experience problems with your submission, please contact:


Editorial Office 'Neuroepidemiology'
National Institute for Stroke and
Applied Neurosciences
Auckland University of Technology
AA254, 90 Akoranga Drive, Northcote 0627
Private Bag 92006, Auckland 1142
New Zealand
Fax +64 9 921 9620

All manuscripts must be accompanied by a short cover letter to the Editor signed by all authors stating that they agree to the publication of the manuscript. The cover letter should be uploaded during the online submission process.

Names, postal and e-mail adresses of 5 experts in the appropriate area of research should accompany each manuscript. Referees suggested should not be from the same institution or be research collaborators of the author(s).


All manuscripts are subject to editorial review.

Manuscripts are received with the explicit understanding that they have not been previously published elsewhere and are not under simultaneous consideration by any other publication. Submission of an article for publication implies transfer of copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Neuroepidemiology' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.

Conflicts of Interest

Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.


Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.

Categories of Manuscripts

(Word limits include tables, illustrations and references)

Original Papers are full-length research papers which will be considered for the journal. Articles cover topics relevant to neuroepidemiological studies (max. 2,500 words).

Reviews are comprehensive, state-of-the-art papers (systematic reviews or meta-analyses) of important epidemiological or clinical problems relevant to neurological disorders. Reviews may be invited by the Editor or they may be unsolicited views (max. 5,000 words), although in the latter, we ask the author to send the Editor a short outline first (300–400 words) to ensure that a review on a similar subject has not already been commissioned. Manuscripts will be assessed in-house and those judged suitable will be peer reviewed before an editorial decision is made. An Abstract is required and should be divided into Background, Summary and Key Messages.

Editorials are usually invited by the Editor (max. 1,000 words). Please send suggestions to the Editor.

Methods in Neuroepidemiology papers dealing with methodological issues in current neuroepidemiologic studies (e.g. recruitment, exclusion and inclusion criteria, methodological evaluation, novel approaches to clinical trials, statistical analyses and follow-up problems and solutions), particularly with regard to on-going large population-based studies, controlled clinical trials, cohort and case-control studies are welcome (max. 5,000 words).

Letters to the Editor and Opinions. Manuscripts of max. 500 words, 1 figure or table and max. 10 references are considered for publication provided they describe a novel observation or add pertinent new information into the epidemiology or health care of a neurological disease.

Reporting Guidelines

According to the type of the article, we recommend authors to adhere to the following reporting guidelines:

Descriptive incidence studies: The STROND guidelines [Eur J Epidemiol 2015;30:569–576 and Neuroepidemiology 2015;45:71–72].

Observational non-experimental studies (cohort, case-control, and cross-sectional studies): The STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) statement (www.strobe-statement.org).

Reporting randomized controlled trials: The CONSORT (Consolidated Standards of Reporting Trials) statement (www.consort-statement.org).

Randomized controlled trials of herbal interventions: The elaborated CONSORT statement [Ann Intern Med 2006;144:364–367].

Meta-analysis of randomized controlled trials: The Cochrane Collaboration guidelines (www.cochrane.org/resources/handbook).

Meta-analysis of observational studies in epidemiology: The MOOSE (Meta-analysis of Observational Studies in Epidemiology) statement (JAMA 2000;283:2008–2012).

All systematic reviews must describe search strategy, data sources (databases, journals, books, etc) and criteria used to include or exclude studies.

Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).


All manuscripts should be arranged in the following order:
  1. title
  2. key words and abstract
  3. text
  4. acknowledgments and funding
  5. references
  6. tables
  7. figure legends
  8. figures

All manuscripts must be typed in double-space, including references, figure legends, and tables, with 1-inch (2.54 cm) margins on all sides. Number every page, beginning with the abstract, including tables, figure legends, and figures, and cite each figure and table in the text numerically. All references must be cited in the text consecutively and be listed in the References.

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head. The number of figures and tables should also be indicated.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper at the bottom of the title page.

Abstract: The Abstract is essential. It should be printed on a separate page (up to 200 words; any abbreviations must be explained) and structured as follows:
  • Background: Rationale and purpose of the study
  • Methods: How the study was performed (samples and/or population, procedures, analytical methods)
  • Results: The main findings with specific data and their statistical significance, when applicable
  • Conclusions: A succinct interpretation of the data presented

Abstracts of Reviews: Should be divided into the following subsections: Background, Summary and Key Messages. The Background should provide a brief clinical context for the review and is followed by the Summary, which should include a concise description of the main topics covered in the text. The Key Messages encapsulate the main conclusions of the review.

Text: The following are typical main headings used in the text: Introduction, Materials and Methods, Results, Discussion, and Conclusion. Abbreviations must be defined where first mentioned in the abstract and the main text.

Footnotes: Avoid using footnotes in the text. When essential, they are numbered consecutively and typed at the bottom of the appropriate page. In the tables, footnotes are indicated by superscript numerals.

Acknowledgments and funding: This section (when appropriate) should list all sources of funding for the research presented in the manuscript, and substantive contributions of individuals for assistance with the research or manuscript (authors are responsible for ensuring that all persons acknowledged have seen and approved mention of their names in the manuscript). All possible conflicts of interest should also be given here, or state ’no conflicts of interest‘.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. For the reproduction of illustrations, only good drawings and original photographs can be accepted; negatives or photocopies cannot be used. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi.

Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.


Accuracy of reference data is the author’s responsibility. In the text cite references consecutively in Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ’unpublished data‘ and not be included in the reference list. 'In press' citations must have been accepted for publication and the name of the journal or book publisher should be included. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals www.icmje.org).


(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:

(b) Papers published only with DOI numbers only:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 3, revised. Basel, Karger, 1996.

(d) Edited books:
DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137.

Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.

Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org

Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.

Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.

Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.

Page Charges

There are no page charges for manuscripts of 3 printed pages or fewer (including tables, illustrations and references). The allotted size of a paper is equal to 2,500 words or approx. 11 double-spaced manuscript pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.00. Invited Reviews and Methods in Neuroepidemiology papers are exempt of page charges.


Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.


Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.